EDX110

DEVICE2 trials

Sponsors

ConvaTec Inc., Kumasi Centre for Collaborative Research

Conditions

Diabetic Foot UlcerSkin and Connective Tissue DiseasesWound Heal

Phase 3

Evaluation of a nitric oxide generating dressing (EDX110) to improve management of Buruli ulcer disease (BURULINOX)

RecruitingPACTR201812819039144

Kumasi Centre for Collaborative ResearchSkin and Connective Tissue Diseases

Start: 2019-03-01Target: 142Updated: 2026-01-27

Unknown Phase

EDX110 Randomized Control Trial for Treatment of DFUs

RecruitingNCT07209358

ConvaTec Inc.Diabetic Foot Ulcer, Wound Heal

Start: 2025-10-30End: 2026-12-31Target: 298Updated: 2025-12-17